Ì첩ÌåÓý

Kimberly Blumenthal, MD, MSc is an Allergist/Immunologist and drug allergy researcher at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School.  She is also the Director of Allergy/Immunology Clinical Epidemiology Research within the Division of Rheumatology Allergy and Immunology, the Quality and Safety Officer for Allergy at the Edward P. Lawrence Center for Quality and Safety, and the Quality Director for Allergy/Immunology.  Dr. Blumenthal performs drug allergy research that uses methods of epidemiology, informatics, economics, and decision science.  Her research is funded by the NIH and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation.  Dr. Blumenthal is recognized nationally for having created innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in the hospital that have since been adopted by other hospitals throughout the US and internationally, broadly referenced, and incorporated into expert recommendations.

Dr. Blumenthal graduated from Columbia University with a BA in Economics.  She studied medicine at Yale University School of Medicine, which she completed in 2009, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.